Five Entrepreneurship Trends to Watch in 2015

By: Joan Siefert Rose, President of CED By tapping into the country’s largest network of entrepreneurs, investors and thought-leaders, the Council for Entrepreneurial Development (CED) is applying its unique perspective on entrepreneurship in North Carolina to predict the trends to expect here and in other entrepreneurial hubs across the country in the year ahead.  Here’s

Read More

CED Member David Chapin Publishes the ‘Definitive Book on Marketing’ for Life Science Industries

David Chapin, CEO of Forma Life Science Marketing, has published Making the Complex Compelling: Creating High-Performance Marketing in the Life Sciences. Making the Complex Compelling is designed for life science investors, researchers, and business development and sales executives who are eager to better engage their audiences and increase sales and margins. The book introduces readers

Read More

Innovate Biopharmaceuticals Acquires Late-stage Pancreatic Imaging Assets

Innovate Biopharmaceuticals, Inc. has entered into an agreement to purchase all assets related to a synthetic version of human secretin from Repligen Corporation. Repligen has completed a Phase 3 study demonstrating that its synthetic secretin improved detection of pancreatic duct abnormalities in patients with known or suspected pancreatitis. The acquisition includes a New Drug Application

Read More

Phononic Raises $44.5 Million in Series D Funding

Phononic Raises $44.5 Million in Series D Funding Phononic, a consumer products company reinventing cooling and heating, has secured $44.5 million in Series D funding. The funds will be used to drive sales of the company’s solid state solutions in Cold Products and Electronics Cooling, penetrate new market opportunities and expand manufacturing capacity. Phononic recently

Read More

Durham’s Advanced Animal Diagnostics Closes $15 Million Series C

Durham’s Advanced Animal Diagnostics Closes $15 Million Series C Durham-based Advanced Animal Diagnostics (AAD) has closed a $15 million Series C round of equity financing, which allows the company to accelerate the commercialization of its current product offering, the QScout® MLD (milk leukocyte differential) test, while also expanding their product line.   AAD develops on-farm

Read More